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Abstract
Antibiotic resistant bacteria have become increasingly widespread in 
the environment and their prevalence is a serious potential problem 
for human health. The rise and spread of this resistance is primarily 
due to the overuse of antibiotics in clinical therapeutics and as growth 
promoters for livestock. Overuse undermines the usefulness of anti-
biotics by giving a selective advantage to microbes that are resistant. 
The problem has been exacerbated by the emergence of bacteria that 
are resistant to multiple antibiotics and by the ability of these resis-
tance determinants to spread between different bacteria via horizontal 
gene transfer. Such transfer can, for example, take place extensively 
in the digestive tract of domestic animals and aquatic environments, 
which can become reservoirs of multiple antibiotic resistant bacteria 
(MARB) and these sources contribute eventually to spread of antibiotic 
resistance to humans
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Introduction
Antibiotics were originally defined as biochemical 
compounds, secreted by microorganisms, which 
inhibit the growth of other microorganisms, such 
as bacteria, fungi and protozoa [1]. However, the 
meaning of the term has expanded to include not 
only chemicals of natural origin but also synthet-
ic and semi-synthetic drugs. On the other hand, 
“antibiotic”now tends to be used more narrowly to 
indicate antibacterial substances, while “antimicro-
bials” or “antimicrobial drugs” are more appropri-
ate general terms that include all chemotherapeutic 
agents used against microorganisms, whether they 
a bacteria, fungi or protozoa. 
In this article, “antibiotic” will include synthetic and 
semi-synthetic antibacterial drugs or naturally oc-
curring antibacterial compound. The first such com-
pounds to be produced on a large-scale and widely 
The InTernaTIonal arabIc Journal of anTImIcrobIal agenTs
Issn 2174-9094
2014
Vol. 4 No. 3:2
doi: 10.3823/754
This article is available from: www.iajaa.org   /   www.medbrary.com2
used were the sulfonamides (developed by Bayer 
AG) and sulfanilamide in the 1930s. However, the 
era of antibiotics could really be said to have begun 
with the mass production of penicillin during World 
War II. Penicillin and its derivatives were the first 
drugs to be effective against Streptococcus, Staphy-
lococcus and other bacteria that previously caused 
very serious infections. Further research in the 1940s 
and 1950s turned up new antibiotics produced by 
soil microorganisms, as well as semi-synthetic de-
rivatives of penicillin with broader activity.
There are many uses for antibiotics, the most famil-
iar being their use in medicine. In the last 60 years, 
they have become a mainstay of the physician’s 
arsenal for fighting bacterial infections in humans, 
and deaths from such infections have become much 
less common, at least in countries where antibiot-
ics and good health care are available. Recently it 
has also been found that antibiotic compounds can 
be of great utility in treating severe malnutrition [2-
3]. Less well-known among the general public are 
the uses of antibiotic compounds in plant agricul-
ture, in aquaculture, for therapy and prophylaxis in 
veterinary medicine, and for growth promotion of 
animals, mainly cattle and poultry [4-5]. 
In the 1940s, it was observed that chickens fed with 
food containing tetracycline grew faster than those 
with no antibiotic [6]. As a result, many antimicrobial 
drugs improve the average daily weight of livestock, 
especially cattle. Antibiotics such as bambermycins, 
carbadox and bacitracin, are mostly used for growth 
promotion and prophylaxis. Other prophylactic an-
timicrobial drugs include β-lactam drugs (penicillins 
and cephalosporins), tetracyclines and quinolones. 
Tetracycline residues in Oman were found in chicken 
[7-8]. These antibiotics are also used widely in hu-
man medicine [6]. Antibiotics also have been used for 
treatment of plant diseases since the 1950s [9]. The 
excessive use of antibiotics has also been reported in 
aquaculture [10]. Nhiem et al. [11] reported antibiotic 
residues in marketed pork in Vietnam. In Indo-China, 
antibiotic residues have been found in shrimp ponds, 
rivers, canals and other habitats [12]. 
The use of antibiotics as growth promoters is par-
ticularly significant. It has been suggested that 40% 
of the antibiotic production in the United States is 
used in stock feeds [13]. However, others report that 
the figure may be closer to 80% [14]. Although the 
use of antibiotics under the control of veterinary 
prescription, farmers still tend to use them inten-
sively, which led to successful poultry industry, but 
have caused the emergence of antibiotic resistant 
strains.
Nevertheless, awareness of public health associated 
with the usage of antibiotics is increasingly on the 
rise specifically the emergence of multi-drug resis-
tant strains [7, 15]. Health officials worldwide recog-
nize that the increase in the number of multi-drug 
resistant bacteria is a significant problem, particu-
larly with the decline in the number of new antibiot-
ics available for treatment, and the low number of 
new antibiotics approved per year.
Antibiotic resistance  
and its origins
Whenever antibiotics are used, and especially when 
they are misused or overused, bacteria can arise 
that are no longer vulnerable to the drugs. This is 
termed as antibiotic resistance. Resistance describes 
the relative bacterial insusceptibility to a specific 
treatment under a particular set of conditions. The 
development of bacterial resistance is a natural evo-
lutionary response in the presence of the selective 
pressure of antimicrobial drug usage. Under opti-
mal conditions, bacteria multiply very rapidly, with 
generation times of minutes to hours. This allows 
ample opportunity for spontaneous mutations to 
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occur, so in any population of bacteria significant 
genetic variation will naturally occur. It is estimated 
that a genetic mutation that confers some measure 
of resistance, usually to a single antibiotic substance, 
arises in a frequency of once in every 1 million to 
1 billion cells [16]. When bacteria are exposed to 
the drug at a concentration less than what would 
be necessary to inhibit the growth of or kill the 
entire population, those cells that carry resistance 
determinants have a selective advantage in survival 
and growth over those that do not. Thus, resistant 
bacteria become more predominant by a process of 
Darwinian natural selection.
Resistance is a natural phenomenon that is as an-
cient as the antibiotic compounds themselves, hav-
ing developed in antibiotic-producing organisms to 
protect them from their own products and evolv-
ing in other originally susceptible organisms that live 
in close proximity to the antibiotic-producers, for 
example in the soil [6]. In short, resistance deter-
minants exist in nature where, as will be discussed 
below, they have the potential to be transferred 
horizontally to human pathogens [17]. However, 
clearly not all bacteria are resistant to naturally oc-
curring antibiotics. If they were, compounds such as 
penicillin and streptomycin could not have been dis-
covered and put to use against human pathogens. 
Those bacteria which are susceptible presumably 
never evolved resistance because they were never 
exposed to the antibiotics in nature. The same is 
obviously true of antimicrobial compounds.
Although some bacteria were exposed to naturally 
occurring antibiotics and evolved resistance at early 
stages of evolution, since the discovery and exploi-
tation of antibiotics by man began in the 1940s 
many more bacteria have been exposed to these 
agents. As a result, resistance to both naturally oc-
curring and synthetic antibiotics has become wide-
spread among many species and strains of bacte-
ria that were previously susceptible. It has become 
much more common to isolate antibiotic resistant 
bacteria from patients, from farm animals and from 
the environment.
The prevalence of resistance resulted from complex 
interactions among antibiotics, microorganisms, 
hosts and the environment. However, the main fac-
tor that determines the rate of emergence and the 
degree of antibiotic resistance is the presence of the 
antibiotics themselves resulting in selection pressure 
[18]. Under this selection, the dominant resistant 
strains spread widely to animal hosts [6]. Therefore, 
the main cause of the emerging antibiotic resistant 
bacteria is exposure to antibiotics and how fre-
quently and much the drugs are being used [19]. As 
a result of treatment with antibiotics in health care, 
antimicrobial resistance can arise in bacteria of the 
human body in both pathogenic and normal flora, 
for example, their presence in the colon. Physicians 
can minimize the emergence of resistance by pre-
scribing antibiotics carefully and prudently, but this 
is not always done. In many countries antibacterial 
drugs are readily available over the counter (OTC), so 
they can be easily obtained by the community and 
used improperly. This contributes to the selection 
of resistant strains, especially when broad-spectrum 
antibiotics are used [20-21]. Antibiotic resistance can 
also evolve in animals, where usage of antibiotics 
for growth promotion is the most dominant fac-
tor contributing to the selection and emergence of 
antibiotic-resistant bacteria [22]. The more frequent 
antibiotic used, the more resistance will develop in 
both pathogens and normal flora bacteria in the 
exposed population of animals [6, 23].
Finally, antibiotic resistance can emerge in the en-
vironment. In nature, resistant bacteria may be se-
lected as a result of exposure to antibiotics pro-
duced by organisms in the soil. However, a much 
more significant factor is the selection imposed by 
exposure to antimicrobial residues in waste prod-
ucts from human activity. These residues may come 
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from treated animals or humans, disposal of unused 
drugs, or runoff from agricultural land [24].
Emergence of Multiple 
Antibiotic Resistant Bacteria 
(MARB)
The use or overuse of antibiotics can lead to the 
emergence of antibiotic-resistant bacteria, especially 
when broad-spectrum antibiotics are used. Bacte-
rial resistance to a single antibiotic might appear 
to be a minor problem, because so many different 
antibiotics are available. However, as the use of an-
tibiotics has become widespread, bacterial strains 
that are resistant to multiple antibiotics have be-
come increasingly common. In some cases, patho-
genic bacteria have emerged that are resistant to all, 
or almost all, of the currently available antibiotics. 
Clearly MARB have serious implications for human 
and animal health, and for the environment [23]. If 
resistance can make antibiotics useless, it raises the 
spectra of a return to the pre-antibiotic age when 
medicine was nearly powerless to fight infection. 
Bacterial antibiotic resistant infections double the 
risk of disease, hospitalization and death compared 
to drug-susceptible bacteria [25]. For the first time 
a comprehensive global study collected from 114 
countries shows a threatening situation of multiple 
antibiotic resistant microbes and that the antibiotics 
are declining in their efficiency in controlling mi-
crobes [26]. If this situation continues then within few 
years, infections which were once easily treatable 
will become uncontrollable. MARB could in principle 
arise as a result of mutations when a population of 
susceptible bacteria is exposed to sub-lethal con-
centrations of two or more antibiotics at the same 
time, or when a population that is already resistant 
to one antibiotic is exposed to another. However, 
a more important route to multiple antibiotic re-
sistance, and the spread of antibiotic resistance in 
general, involves genetic rearrangements and the 
horizontal transfer of resistance determinants from 
one bacterium to another. Horizontal transfer re-
fers to the transmission (via the bacterial processes 
of conjugation, transformation or transduction), 
from donors to recipients, of resistance genes 
already present in the bacterial world [27]. This 
sort of transfer apparently occurs quite commonly 
within environmental reservoirs where resistance 
genes are generated by mutation, where bacteria 
and antimicrobial agents coexist, and where the 
bacterial population is high. There is strong evi-
dence for horizontal transfer of resistance genes 
between bacteria that cause infections in animals 
and those that cause infection in humans [28]. It 
was reported that environmental isolates of MARB 
could transfer resistance to previously susceptible 
normal flora Escherichia coli [29].
Widespread occurrence of 
plasmids carrying antibiotic 
resistancegenes
Antibiotic resistance in pathogens makes it difficult 
to treat human infections efficiently, but nonpatho-
genic antibiotic resistance bacteria are also important 
in transmitting resistance genes to other bacteria by 
means of transmissible resistance factors (R-factors) 
[30]. Research indicates that plasmids, and especially 
R-plasmids, are very common in bacteria. In one 
of our studies, plasmid DNA analysis of 47 differ-
ent strains of E. coli showed a plasmid occurrence 
rate of 100 %. The size of the extracted plasmids 
ranged from 1.2 to 54.3 kilobases (kb), while the 
number of different sized plasmids per cell ranged 
from one to nine. However, some strains resistant 
to one antibiotic had more than one plasmid, oth-
ers containing just one or two plasmids were resis-
tant to many antibiotics [31]. Bacteria isolated from 
humans with single plasmids carrying resistance to 
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a large number of antibiotics were also reported 
[32]. These plasmids ranged in size from 4.7 to 10.8 
kb. Analysis of 28 Salmonella spp strains showed 
that the plasmid DNA in various strains ranged in 
size from 3.1 kb to 32 kb. It has been shown that 
a similar range of bacterial R-plasmids can be iso-
lated from fish [33]. Plasmid occurrence at a rate of 
81.7% was observed in E. coli isolates from chicken 
in Malaysia [34]. The maximum number of different 
plasmids per cell in this study was eight with sizes 
ranging from 1.8 to 180.3 Kb. It was also reported 
that 2.8% of the E. coli isolates harbored 8 plasmids 
and were resistant to 12 antibiotics [34]. They con-
cluded that E. coli with a higher number of plasmids 
possessed wider resistance to antibiotics. However, 
it has been observed that E. coli isolates with only 
three plasmids were also resistant to 12 antibiotics 
[31]. Others found that E. coli drug-resistant isolates 
carried plasmids ranged from 1.5 kb to 54 kb in 
size, with one to six different sizes in each isolate 
[35]. In addition, multiple antibiotic resistant E. coli 
isolates harboring 4.3 kb and 23.1 kb plasmids were 
observed [36]. In another study, a common 54 kb 
plasmid was harbored by 55 % of local isolates of 
Enterobacteriaceae from humans and chickens in 
Turkey [37], while in Jordan, it was reported that the 
54 kb plasmid was common in isolates from leafy 
vegetables [38]. Others observed E. coli plasmids 
isolated from chicken fecal samples with 21.5 kb 
to 27.4 kb [39]. According to Doetkott et al. [40], 
56.7% of E. coli isolates from chickens had one 
to four plasmids greater than 50 kb in size. These 
examples show that plasmids, and particularly R-
plasmids, are commonly observed in environmen-
tal bacterial isolates. They are regularly found not 
only in bacteria isolated from humans, but also in 
isolates from farm animals, such as chickens. This 
suggests that foul may be important reservoirs of 
antimicrobial-resistant organisms. The prevalence of 
resistance determinants on mobile genetic elements 
means that it is possible, indeed likely, that acquired 
characteristics will be shared with other bacteria 
[41], which can then spread to other animals, to 
humans, and to the environment [42]. 
Food-Producing animals as 
breeding grounds for antibiotic 
resistance
Bacterial strains showing resistance to multiple an-
timicrobial drugs are clearly a public health con-
cern and so it is important to understand how and 
where they emerge. Bacterial antibiotic resistance 
can arise in humans, animals, or the environment, 
and is usually associated with excessive, inappropri-
ate and indiscriminate usage of antimicrobials [43]. 
It was reported that bacterial strains of human ori-
gin were resistant to a larger number of antibiotics 
than those from animal, sewage and water sources 
[44]. This suggests that excessive or inappropriate 
use of antibiotics in human medicine plays a crucial 
role in the genesis and persistence of resistant hu-
man pathogens. However, antimicrobials usage in 
animals contributes to the emergence of resistant 
variants. For example, some investigators reported 
the emergence of verocytotoxin-producing E. coli, 
including E. coli O157:H7 [39]. The use of antibi-
otics for treatment of E. coli O157:H7 in human 
infections is not recommended. It is reported that 
sub-therapeutic administration levels of antibiotic 
to animals is a contributing factor. E. coli O157:H7 
resistant isolates present in animal drinking-water 
is evidence that the strains spread from one animal 
to another [45]. Both humans and animals are ob-
vious breeding grounds for resistant bacteria, but 
animals and food-producing animals in particular, 
may actually be more important sources. The di-
gestive tracts of animals are the largest reservoirs 
of resistance genes. They form an ideal climate for 
horizontal gene transfer among both pathogenic 
and commensal species, as has been well docu-
mented [18]. Resistance genes in Salmonella spp. 
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were transferred to E. coli as well as between other 
normal intestinal flora [46]. 
Large amounts of different drugs are used in ani-
mals as growth promoters, as well as for disease 
prevention and treatment purposes [14, 43]. These 
practices are thought to have caused an increased 
frequency of multiple resistance genes in the animal 
gut [23]. Enteric bacteria in livestock are exposed 
to great selective pressure because in some coun-
tries more than half and by some reports as much 
as 80%, of the production of antimicrobial agents 
is used as feed additives for food-producing ani-
mals [14]. As a result of extensive antibiotic use and 
abuse, Enterobacteriaceae and other normal intesti-
nal flora are the microorganisms most often exposed 
to antibiotics and consequently they are the ones 
that most commonly develop multiple antibiotic re-
sistance. Antibiotic resistant Gram-negative bacilli 
from fecal specimens, especially Enterobacteriace-
ae, have been of particular interest because of the 
increasing risk of gastroenteritis caused by strains 
carrying R-plasmids. E. coli is the most common 
facultative bacterium in the intestinal microbiota of 
humans and many animals [47] has been reported 
to be a significant reservoir for genes encoding 
antimicrobial drug resistance [48]. The widespread 
use of various antibiotics as growth promoters and 
as treatments for chicken infections has selected 
antibiotic-resistant strains and has made chickens 
an important potential source of multiple antibiotic-
resistant bacteria [7]. Since the selection pressure for 
antibiotic resistance in bacteria is high in poultry, 
their fecal flora contains a relatively high proportion 
of resistant bacteria [22]. Numerous studies have 
found high levels of antibiotic-resistance among the 
intestinal flora of chickens. A normal flora, E. coli, 
in chicken intestines is always exposed to antibiot-
ics. It is considered the major carrier of resistance 
combinations and it is transferable in fecal flora [49]. 
In Saudi Arabia, E. coli isolated from chickens were 
highly resistant to many antibiotics [50]. In a later 
study [21], they reported that 37.4% of strains iso-
lated from chicken were resistant to gentamycin. 
They confirmed that gentamycin is heavily used on 
chicken farms where it is administered to almost all 
three-day-old chicks to treat or prevent infections. 
In their study, most Gram-negative organisms were 
highly resistant to this drug. Other studies reported 
resistance of E. coli to gentamycin [39, 42]. It was 
reported that low-dose of tetracycline in poultry 
feed affected the chicken intestinal flora. Resistance 
developed rapidly under antibiotic pressure and that 
resistance to single-drugs eventually becomes mul-
tidrug-resistance. It was also found that the intes-
tinal bacteria of individuals who were exposed to 
antimicrobial agents acquired resistance and were 
able to spread to other chickens and humans liv-
ing and working on the farm [51]. Chicken isolates 
from slaughterhouse in Spain were highly resistant 
to many antibiotics [13]. Others reported that E. coli 
isolates were multiple resistance to most antibiotics 
[42-43, 52-54].
Crowding and sanitation are major factors in the 
selection of antimicrobial resistance in bacteria 
[22]. These conditions are used extensively in poul-
try farming, which explains the high degree of re-
sistance observed in E. coli of poultry feces cited 
above. In Oman, 100% of the isolates from chick-
ens were resistant to antibiotics [42], whereas in an 
earlier study samples collected in Oman in 1986, 
only 30% of the isolates were multiple resistant to 
antibiotics [43]. These results indicate that antibiotic 
resistance is increasing rapidly in the poultry indus-
try. Although regulations forbid the use of antibiot-
ics in several countries, antibiotics are still used in 
poultry industry. 
In summary, the extensive antibiotic usage for 
prophylactic and growth promotion purposes has 
caused the selection of resistance in both patho-
genic and non-pathogenic bacteria in the animal 
gut. Consequently, food-producing animals have 
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become important breeding grounds for antibiotic 
resistant bacteria. This is a serious concern for two 
reasons. First, the presence of resistance makes the 
antibiotics less useful for their intended purposes of 
prophylaxis and treatment and reduces their eco-
nomic value as growth promoters. Second, these 
animals and their wastes have become potential 
sources for the spread of these bacteria to the en-
vironment and humans.
Spread of antibiotic resistance 
from animals to humans
The mechanisms of MARB spreading from animals 
to humans remain somewhat controversial; coloni-
zation of the human intestinal tract with resistant 
bacteria from chickens was clearly demonstrated 
[47]. At slaughterhouses and poultry farms, both 
pathogenic and nonpathogenic strains from domes-
tic animals can spread to humans by eating contam-
inated egg, meat and dairy products of the infected 
animals [16, 22, 36, 47, 55, 56, 57].
Infiltration of antibiotics and 
antibiotic resistance into the 
environment
Resistant bacteria spread to the environment by sev-
eral different routes including treated and untreated 
sewage effluents, sludge and agricultural runoff [42, 
58-63). Pharmaceuticals can be dispersed by the 
same routes and also important for the emergence 
and spread of antibiotic resistance in the environ-
ment [64]. The widespread release of disinfectants 
and pharmaceutical products related to agricultural, 
medical and veterinary practices is believed to be 
the main contributors in the emergence of MARB 
[5, 63, 65-67]. Many antibiotics are poorly absorbed 
in the animal digestive tract, and it is estimated that 
25% to 75% are excreted in feces [23]. However, 
antibiotics such as tetracyclineare found in chicken 
liver, intestines and kidney, and these antibiotics 
find their way into the environment through urine 
mixed with chicken manure [8, 68]. Antimicrobial 
drugs used for animals enter the environment when 
manure is used as organic fertilizer. Since the annual 
waste production of waste from livestock is nearly 
180 million tons in the United States, this waste is 
potentially a significant source of pharmaceuticals 
released into the environment. These antibiotics 
may end up either in soil, sediment, ground water 
or surface water where they may exert significant 
selective pressure favoring resistant bacteria [6].
Antibiotic-resistant bacteria can also enter the en-
vironment in runoff from feedlots and fields fertil-
ized with manure. In a study of a pristine river in 
the Rocky Mountains, it was reported that certain 
resistance genes accumulated downstream and that 
they were primarily contributed by animal feeding 
operations located upstream and only to a lesser 
extent by wastewater treatment facilities [69]. In 
Ontario, private wells where manure is commonly 
applied on farms are frequently contaminated with 
bacteria. Feces contaminated effluents from animal 
farms infiltrate wells [70]. In addition, waste from 
septic tanks and manure storage sites can seep or 
spill into surrounding watersheds and ground water 
sources [71]. In West Virginia, it was reported that all 
coliforms and nearly all non-coliforms were multiple 
resistant to antibiotics [29]. In Oman, treated and 
untreated sewage effluents played an important 
role in the underground water pollution. In some 
contaminated wells E. coli was found to be multiple 
resistant to antibiotics, which a clear indication that 
contamination was from sewage effluents [72].
Human waste streams can also be an important 
source of antibiotics in the environment. Conse-
quently, hospital and municipal wastewater sys-
tems may play an important role in the selection of 
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antibiotic-resistant bacteria [5, 66-67]. Depending 
on their use, pharmaceuticals enter the environment 
through different pathways [64]. Compounds used 
in medicine and their metabolites are excreted with 
feces and urine into sewage. Disposal of surplus 
drugs into the sewer system via toilets may also 
be a significant source, although it is unknown 
to what extent this occurs. Antibiotics have been 
clearly detected in wastewater treatment facilities 
[73], but they are only partially eliminated during 
the sewage-treatment process [60, 65]. Some are 
subsequently released via the contaminated effluent 
into the aquatic environment [60, 64, 74-77] where, 
they are probably slowly transformed by biologi-
cal and physical processes [78]. Resistant bacteria 
bred in the human gut can also enter the environ-
ment via sewage. Untreated sewage is the most 
hazardous contaminant in the environment due to 
its large volume, its human waste component, and 
its ability to transmit waterborne diseases including 
viruses, bacterial pathogens and other organisms 
that are endemic in the community. In arid hot cli-
mate regions, or where there is a high dependence 
on underground potable water, the transmission of 
MARB is greatly increase as a result of crack septic 
tanks, cesspit and inadequate recycled sewage wa-
ter [61, 72]. Although untreated sewage can obvi-
ously be a source of antibiotic resistant bacteria in 
the environment, treated domestic wastewater can 
also be a source [59, 72].
The diagram in Figure 1 summarizes the various fac-
tors involved in the genesis and spread of MARB that 
have been discussed in this review. It also portrays the 
relationships between antibiotic usage, human and 
animal infections, and environmental contamination. 
As Figure 1 indicates, dispersal of antibiotics, MARB 
and other pollutants in the environment, which even-
tually manifested as contamination of ecosystems 
and the living organisms that inhabit them.
Figure 1. Relationships between antibiotic uses and environmental contamination.
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